Adolescent decision making about participation in a hypothetical HIV vaccine trial

Adolescent Trials Network for HIV/AIDS Interventions

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent with attention to developmental differences. Methods: As part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their decision making process when deciding whether or not to enroll in and HIV vaccine trial. An ethnographic content analysis approach was utilized. Results: Twelve concepts related to adolescents' decision-making about participation in an HIV vaccine trial were identified and mapped onto Appelbaum and Grisso's four components of decision making capacity including understanding of vaccines and how they work, the purpose of the study, trial procedures, and perceived trial risks and benefits, an appreciation of their own situation, the discussion and weighing of risks and benefits, discussing the need to consult with others about participation, motivations for participation, and their choice to participate. Conclusion: The results of this study suggest that most adolescents at high risk for HIV demonstrate the key abilities needed to make meaningful decisions about HIV vaccine clinical trial participation.

Original languageEnglish
Pages (from-to)1331-1337
Number of pages7
JournalVaccine
Volume33
Issue number11
DOIs
StatePublished - Mar 10 2015

Fingerprint

AIDS Vaccines
decision making
Decision Making
vaccines
clinical trials
Clinical Trials
Aptitude
Informed Consent
Motivation
Vaccines
interviews
HIV
Interviews
gender

Keywords

  • Adolescent
  • Decision making
  • HIV vaccine trial
  • Qualitative research

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Adolescent decision making about participation in a hypothetical HIV vaccine trial. / Adolescent Trials Network for HIV/AIDS Interventions.

In: Vaccine, Vol. 33, No. 11, 10.03.2015, p. 1331-1337.

Research output: Contribution to journalArticle

Adolescent Trials Network for HIV/AIDS Interventions 2015, 'Adolescent decision making about participation in a hypothetical HIV vaccine trial', Vaccine, vol. 33, no. 11, pp. 1331-1337. https://doi.org/10.1016/j.vaccine.2015.01.049
Adolescent Trials Network for HIV/AIDS Interventions. / Adolescent decision making about participation in a hypothetical HIV vaccine trial. In: Vaccine. 2015 ; Vol. 33, No. 11. pp. 1331-1337.
@article{15ca0407cedc4ad08b5d55197f2fe2f2,
title = "Adolescent decision making about participation in a hypothetical HIV vaccine trial",
abstract = "Purpose: The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent with attention to developmental differences. Methods: As part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their decision making process when deciding whether or not to enroll in and HIV vaccine trial. An ethnographic content analysis approach was utilized. Results: Twelve concepts related to adolescents' decision-making about participation in an HIV vaccine trial were identified and mapped onto Appelbaum and Grisso's four components of decision making capacity including understanding of vaccines and how they work, the purpose of the study, trial procedures, and perceived trial risks and benefits, an appreciation of their own situation, the discussion and weighing of risks and benefits, discussing the need to consult with others about participation, motivations for participation, and their choice to participate. Conclusion: The results of this study suggest that most adolescents at high risk for HIV demonstrate the key abilities needed to make meaningful decisions about HIV vaccine clinical trial participation.",
keywords = "Adolescent, Decision making, HIV vaccine trial, Qualitative research",
author = "{Adolescent Trials Network for HIV/AIDS Interventions} and Alexander, {Andreia B.} and Mary Ott and Lally, {Michelle A.} and Kevin Sniecinski and Alyne Baker and Gregory Zimet",
year = "2015",
month = "3",
day = "10",
doi = "10.1016/j.vaccine.2015.01.049",
language = "English",
volume = "33",
pages = "1331--1337",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Adolescent decision making about participation in a hypothetical HIV vaccine trial

AU - Adolescent Trials Network for HIV/AIDS Interventions

AU - Alexander, Andreia B.

AU - Ott, Mary

AU - Lally, Michelle A.

AU - Sniecinski, Kevin

AU - Baker, Alyne

AU - Zimet, Gregory

PY - 2015/3/10

Y1 - 2015/3/10

N2 - Purpose: The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent with attention to developmental differences. Methods: As part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their decision making process when deciding whether or not to enroll in and HIV vaccine trial. An ethnographic content analysis approach was utilized. Results: Twelve concepts related to adolescents' decision-making about participation in an HIV vaccine trial were identified and mapped onto Appelbaum and Grisso's four components of decision making capacity including understanding of vaccines and how they work, the purpose of the study, trial procedures, and perceived trial risks and benefits, an appreciation of their own situation, the discussion and weighing of risks and benefits, discussing the need to consult with others about participation, motivations for participation, and their choice to participate. Conclusion: The results of this study suggest that most adolescents at high risk for HIV demonstrate the key abilities needed to make meaningful decisions about HIV vaccine clinical trial participation.

AB - Purpose: The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent with attention to developmental differences. Methods: As part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their decision making process when deciding whether or not to enroll in and HIV vaccine trial. An ethnographic content analysis approach was utilized. Results: Twelve concepts related to adolescents' decision-making about participation in an HIV vaccine trial were identified and mapped onto Appelbaum and Grisso's four components of decision making capacity including understanding of vaccines and how they work, the purpose of the study, trial procedures, and perceived trial risks and benefits, an appreciation of their own situation, the discussion and weighing of risks and benefits, discussing the need to consult with others about participation, motivations for participation, and their choice to participate. Conclusion: The results of this study suggest that most adolescents at high risk for HIV demonstrate the key abilities needed to make meaningful decisions about HIV vaccine clinical trial participation.

KW - Adolescent

KW - Decision making

KW - HIV vaccine trial

KW - Qualitative research

UR - http://www.scopus.com/inward/record.url?scp=84924077737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924077737&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.01.049

DO - 10.1016/j.vaccine.2015.01.049

M3 - Article

VL - 33

SP - 1331

EP - 1337

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -